Table 1.

Treatment-related adverse events.

	Bintrafusp alfa, n (%) N = 32
	Any grade	Grade 3
Any TRAE	22 (68.8)	4 (12.5)
Nausea	6 (18.8)	0
Anemia	5 (15.6)	1 (3.1)
Diarrhea	5 (15.6)	0
Infusion-related reaction	5 (15.6)	0
Decreased appetite	4 (12.5)	0
Fatigue	4 (12.5)	1 (3.1)
Myalgia	3 (9.4)	0
Pyrexia	3 (9.4)	0
Rash	3 (9.4)	0
Vomiting	3 (9.4)	0
Abdominal pain	2 (6.3)	0
Dermatitis acneiform	2 (6.3)	0
Malaise	2 (6.3)	0
Rash maculopapular	2 (6.3)	0
Stomatitis	2 (6.3)	0
Adrenal insufficiency	1 (3.1)	1 (3.1)
Blood bilirubin increased	1 (3.1)	1 (3.1)
Enteritis	1 (3.1)	1 (3.1)